The effect of 2-amino-3-phosphonopropionic acid (AP-3) in the gerbil model of cerebral ischaemia

Mark Maginn, Maeve Caldwell, J. P. Kelly, B. E. Leonard

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

19 Citations (Scopus)

Abstract

The effect of 2-amino-3-phosphonopropionate (AP-3), a metabotropic glutamate receptor antagonist on behavioural and histological changes following global ischaemia was investigated on the Mongolian gerbil. Ischaemia was induced by bilateral carotid occlusion for 5 min. AP-3 was administered i.p. (25 or 250 mg/kg) 30 min before and 24 h after surgery. Significant neuroprotection was observed 96 h after surgery to cells in the CA1 region of the hippocampus in drug treated animals. AP-3 (250 mg/kg) significantly attenuated the increase in locomotor activity measured 72 h after surgery. These results suggest that metabotropic glutamate receptors play a role in the neurodegeneration seen following ischaemia.

Original languageEnglish
Pages (from-to)259-262
Number of pages4
JournalEuropean Journal of Pharmacology
Volume282
Issue number1-3
DOIs
Publication statusPublished - 25 Aug 1995

Keywords

  • AP-3 (2-amino-3-phosphonopropionate)
  • Ischemia
  • Metabotropic glutamate receptor

Fingerprint

Dive into the research topics of 'The effect of 2-amino-3-phosphonopropionic acid (AP-3) in the gerbil model of cerebral ischaemia'. Together they form a unique fingerprint.

Cite this